|
1
|
Nguyen T and Zuniga R: Skin conditions:
benign nodular skin lesions. FP Essent. 407:24–30. 2013.PubMed/NCBI
|
|
2
|
Bancroft LW, Kransdorf MJ, Peterson JJ and
O'Connor MI: Benign fatty tumors: classification, clinical course,
imaging appearance, and treatment. Skeletal Radiol. 35:719–733.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paunipagar BK, Griffith JF, Rasalkar DD,
Chow LTC, Kumta SM and Ahuja A: Ultrasound features of deep-seated
lipomas. Insights into Imaging. 1:149–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miao C, Liu D, Zhang F, Wang Y, Zhang Y,
Yu J, Zhang Z, Liu G, Li B, Liu X and Luo C: Association of FPGS
genetic polymorphisms with primary retroperitoneal liposarcoma. Sci
Rep. 5:90792015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zagars GK, Goswitz MS and Pollack A:
Liposarcoma: outcome and prognostic factors following conservation
surgery and radiation therapy. Int J Radiat Oncol Biol Phys.
36:311–319. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clay MR, Martinez AP, Weiss SW and Edgar
MA: MDM2 amplification in problematic lipomatous tumors: Analysis
of FISH testing criteria. Am J Surg Pathol. 39:1433–1439. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dei Tos AP: Liposarcoma: New entities and
evolving concepts. Ann Diagn Pathol. 4:252–266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brisson M, Kashima T, Delaney D, Tirabosco
R, Clarke A, Cro S, Flanagan AM and O'Donnell P: MRI
characteristics of lipoma and atypical lipomatous
tumor/well-differentiated liposarcoma: Retrospective comparison
with histology and MDM2 gene amplification. Skeletal Radiol.
42:635–647. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gaskin CM and Helms CA: Lipomas, lipoma
variants, and well-differentiated liposarcomas (atypical lipomas):
Results of MRI evaluations of 126 consecutive fatty masses. AJR Am
J Roentgenol. 182:733–739. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O'Donnell PW, Griffin AM, Eward WC,
Sternheim A, White LM, Wunder JS and Ferguson PC: Can experienced
observers differentiate between lipoma and well-differentiated
liposarcoma using only MRI? Sarcoma. 2013.982784PubMed/NCBI
|
|
11
|
Hasegawa T, Yamamoto S, Nojima T, Hirose
T, Nikaido T, Yamashiro K and Matsuno Y: Validity and
reproducibility of histologic diagnosis and grading for adult
soft-tissue sarcomas. Hum Pathol. 33:111–115. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nilbert M, Rydholm A, Mitelman F, Meltzer
PS and Mandahl N: Characterization of the 12q13-15 amplicon in soft
tissue tumors. Cancer Genet Cytogenet. 83:32–36. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pilotti S, Torre G Della, Lavarino C, Di
Palma S, Sozzi G, Minoletti F, Rao S, Pasquini G, Azzarelli A,
Rilke F, et al: Distinct mdm2/p53 expression patterns in
liposarcoma subgroups: Implications for different pathogenetic
mechanisms. J Pathol. 181:14–24. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shimada S, Ishizawa T, Ishizawa K,
Matsumura T, Hasegawa T and Hirose T: The value of MDM2 and CDK4
amplification levels using real-time polymerase chain reaction for
the differential diagnosis of liposarcomas and their histologic
mimickers. Hum Pathol. 37:1123–1129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sirvent N, Coindre JM, Maire G, Hostein I,
Keslair F, Guillou L, Ranchere-Vince D, Terrier P and Pedeutour F:
Detection of MDM2-CDK4 amplification by fluorescence in situ
hybridization in 200 paraffin-embedded tumor samples: Utility in
diagnosing adipocytic lesions and comparison with
immunohistochemistry and real-time PCR. Am J Surg Pathol.
31:1476–1489. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sozzi G, Minoletti F, Miozzo M, Sard L,
Musso K, Azzarelli A, Pierotti MA and Pilotti S: Relevance of
cytogenetic and fluorescent in situ hybridization analyses in the
clinical assessment of soft tissue sarcoma. Hum Pathol. 28:134–142.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weiss SW: Lipomatous tumors. Monogr
Pathol. 38:207–239. 1996.PubMed/NCBI
|
|
18
|
Wong DD, Low IC, Peverall J, Robbins PD,
Spagnolo DV, Nairn R, Carey-Smith RL and Wood D: MDM2/CDK4 gene
amplification in large/deep-seated ‘lipomas’: Incidence, predictors
and clinical significance. Pathology. 48:203–209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakayama R, Nemoto T, Takahashi H, Ohta T,
Kawai A, Seki K, Yoshida T, Toyama Y, Ichikawa H and Hasegawa T:
Gene expression analysis of soft tissue sarcomas: Characterization
and reclassification of malignant fibrous histiocytoma. Mod Pathol.
20:749–759. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arbiser ZK, Folpe AL and Weiss SW:
Consultative (expert) second opinions in soft tissue pathology.
Analysis of problem-prone diagnostic situations. Am J Clin Pathol.
116:473–476. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thway K and Fisher C: Histopathological
diagnostic discrepancies in soft tissue tumours referred to a
specialist centre. Sarcoma. 2009:7419752009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thway K, Wang J, Swansbury J, Min T and
Fisher C: Fluorescence in situ hybridization for MDM2 amplification
as a routine ancillary diagnostic tool for suspected
well-differentiated and dedifferentiated liposarcomas: Experience
at a tertiary center. Sarcoma. 2015:8120892015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kimura H, Dobashi Y, Nojima T, Nakamura H,
Yamamoto N, Tsuchiya H, Ikeda H, Sawada-Kitamura S, Oyama T and Ooi
A: Utility of fluorescence in situ hybridization to detect MDM2
amplification in liposarcomas and their morphological mimics. Int J
Clin Exp Pathol. 6:1306–1316. 2013.PubMed/NCBI
|
|
24
|
Miura Y, Keira Y, Ogino J, Nakanishi K,
Noguchi H, Inoue T and Hasegawa T: Detection of specific genetic
abnormalities by fluorescence in situ hybridization in soft tissue
tumors. Pathol Int. 62:16–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakayama T, Toguchida J, Wadayama B, Kanoe
H, Kotoura Y and Sasaki MS: MDM2 gene amplification in bone and
soft-tissue tumors: Association with tumor progression in
differentiated adipose-tissue tumors. Int J Cancer. 64:342–346.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weaver J, Downs-Kelly E, Goldblum JR,
Turner S, Kulkarni S, Tubbs RR, Rubin BP and Skacel M: Fluorescence
in situ hybridization for MDM2 gene amplification as a diagnostic
tool in lipomatous neoplasms. Mod Pathol. 21:943–949. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Diamandis EP: Present and future of cancer
biomarkers. Clin Chem Lab Med. 52:791–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hadj-Hamou NS, Laé M, Almeida A, de la
Grange P, Kirova Y, Sastre-Garau X and Malfoy B: A transcriptome
signature of endothelial lymphatic cells coexists with the chronic
oxidative stress signature in radiation-induced post-radiotherapy
breast angiosarcomas. Carcinogenesis. 33:1399–1405. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Skubitz KM and Skubitz AP:
Characterization of sarcomas by means of gene expression. J Lab
Clin Med. 144:78–91. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tran D, Verma K, Ward K, Diaz D, Kataria
E, Torabi A, Almeida A, Malfoy B, Stratford EW, Mitchell DC, et al:
Functional genomics analysis reveals a MYC signature associated
with a poor clinical prognosis in liposarcomas. Am J Pathol.
185:717–728. 2015. View Article : Google Scholar : PubMed/NCBI
|
